All EDCTP3 calls for proposals are also published on the European Commission’s Funding and Tender opportunities portal.
Global Health Partnership (EDCTP3)
Partnership website: https://www.globalhealth-edctp3.eu/
The partnership aims to deliver new solutions reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities for preparedness and response against reemerging infectious diseases in sub-Saharan Africa and globally. Belgium is member of the EDCTP Association. EDCTP3 was launched in 2022.
The European & Developing Countries Clinical Trials Partnership (EDCTP) exists to accelerate the clinical development of new or improved health technologies for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases.
The Global Health EDCTP3 Joint Undertaking (Global Health EDCTP3) builds on the first and second EDCTP programmes and is a partnership between the EU and the EDCTP Association, whose members are several European and African countries.
The partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
Key figures
- Total budget of Global Health EDCTP3 is 1.6 billon euro
- The partnership includes 40 European & African countries
Participation Flanders
The following organisations based in Flanders are partner in ongoing EDCTP3 projects (2022 & 2023 work programme):
- University of Antwerp in the projects 'SEMA ReACT', 'SNIP-AFRICA', 'GenPath Africa' & 'PROTECT'
- Institute for Tropical Medicine (ITM) in the project 'STROGHAT'
- Ghent University in the project 'NeuroSolve' & 'ODIN'
- Flemish Institute for Biotechnology (VIB) in the project 'ODIN'
- Janssen Pharmaceutica nv in the project 'CTCAN'
Past & current calls for proposals
Since it took off in 2022, EDCTP has launched several calls of proposals. Information on the latest calls for proposals can be found in the 2024 annual work programme. Any further information can be found on the EDCTP3 Calls for proposals webpage.
Key documents
- Draft partnership proposal (August 2020)
- Strategic Research and Innovation Agenda of the GH EDCTP3 (January 2022)
- Policy context: Global health - EDCTP
Contact
Partnership: EC-GLOBAL-HEALTH-EDCTP3@ec.europa.eu
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
-
orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points. -
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents. -
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain. -
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Testimonial
Avia-GIS - Software Technologies for a Healthier World
Avia-GIS is a Belgian innovative SME established in 2001. They have built research and public authority trust over the past 19 years and developed a unique, disruptive software suite - VECMAP® - that supports society to overcome one of its important health threats, the spreading of Pests of Public Health importance.
With the help of a Horizon 2020 SME Instrument Phase 2 project, they will be able to add Integrated Pest Management functionalities and go to the market. With the grant, that was an essential component of their second investment round, Avia-GIS aims at raising its revenue from the current 2 M€ to 14.2 M€ in 2024, and increase the headcount from 15 to 58.
